Scott Charles is leaving Aralez Pharmaceuticals Inc. as CFO to pursue other opportunities, effective Nov. 30.
Michael Kaseta will assume the role of interim CFO along with his current duties as corporate controller, a role he has held since 2016.
Aralez CFO departs; interim CFO named
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Scott Charles is leaving Aralez Pharmaceuticals Inc. as CFO to pursue other opportunities, effective Nov. 30.
Michael Kaseta will assume the role of interim CFO along with his current duties as corporate controller, a role he has held since 2016.